Histiocytosis Treatments
Find Histiocytosis Treatments
Brand Name
Xenpozyme
Generic Name
Olipudase Alfa-Rpcp
View Brand Information FDA approval date: August 29, 2022
Form: Injection
What is Xenpozyme (Olipudase Alfa-Rpcp)?
XENPOZYME is indicated for treatment of non–central nervous system manifestations of acid sphingomyelinase deficiency in adult and pediatric patients. XENPOZYME is a hydrolytic lysosomal sphingomyelin-specific enzyme indicated for treatment of non–central nervous system manifestations of acid sphingomyelinase deficiency in adult and pediatric patients.
Approved To Treat
Top Global Experts
There are no experts for this drug
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment